A potent dual endothelian (ETA/ETB) receptor antagonist optimized from Bosentan (B675900).
相关文献及参考
Clozel, M., et al.: J. Pharmacol. Exp. Ther., 290, 840 (1999),
Dingemanse, J., et al.: Br. J. Clin. Pharmacol., 53, 355 (2002),
Schalcher, C., et al.: Am. Heart J., 142, 340 (2001),
[1]. Clozel M, et al. Pharmacology of tezosentan, new endothelin receptor antagonist designed for parenteral use. J Pharmacol Exp Ther. 1999 Aug;290(2):840-6.